Custom service

Cyclic Peptide Conjugation

Conjugate cyclic peptides to carriers, labels or payloads without breaking the ring

Turnaround: 4–6 weeksTypical scale: 1 – 200 mg cyclic peptideChemistry options: handle-first ring design; orthogonal conjugation on cyclic scaffolds; post-cyclization labeling

Cyclic Peptide Conjugation supports programmes that conjugate cyclic peptides to carriers, labels or payloads without breaking the ring. In a typical engagement we plan the handle-first ring design route first, confirm compatibility with orthogonal conjugation on cyclic scaffolds, and release cyclic conjugate with loading and connectivity QC on a 4–6 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep handle-first ring design as the primary option and hold orthogonal conjugation on cyclic scaffolds in reserve, so that scale-up never depends on an unproven step.

Cyclic targeting motifs on drug conjugates

Biotinylated or fluorescent cyclic probes

Conjugation chemistries that reduce disulfide cycles

Cycles whose ring size is known to be geometrically uncloseable

Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.

Service Highlights

  • Handle-first ring design as the default route, with orthogonal conjugation on cyclic scaffolds held as a proven fallback
  • Post-cyclization labeling worked into the design where the application requires it
  • Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
  • Analytical confirmation of every intermediate before the final release
  • Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
  • Cyclic conjugate with loading and connectivity QC delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Precursor design

    Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Conjugation ring size.

  2. Linear assembly

    The precursor chain is assembled with Fmoc chemistry and handle-first ring design where relevant.

  3. Cyclization

    Ring closure is executed by orthogonal conjugation on cyclic scaffolds under screened dilution and activation conditions.

  4. Isomer separation

    RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.

  5. Characterization

    Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.

  6. Release

    Cyclic conjugate with loading and connectivity QC is documented and released after QC sign-off.

Specifications & timeline

Turnaround
4–6 weeks
Typical scale
1 – 200 mg cyclic peptide
Chemistry options
handle-first ring design; orthogonal conjugation on cyclic scaffolds; post-cyclization labeling
Deliverable
Cyclic conjugate with loading and connectivity QC
QC package
HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
Shipping
Ambient with desiccant; blue ice for sensitive motifs

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.